All blog posts
Total 6 results for
Showing 6 out of 6 results
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
23 November 2023
CMA issues guidance permitting drugs companies to work together on Combination Therapies
31 October 2023
Another chapter in the "pay for delay" saga: General Court rules on the Teva-Cephalon settlement agreement
15 August 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 June 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
09 February 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
Showing 6 out of 6 results